Literature DB >> 33360378

T cell receptor diversity, specificity and promiscuity of functionally heterogeneous human MR1-restricted T cells.

Marco Lepore1, Deborah A Lewinsohn2, David M Lewinsohn3.   

Abstract

The monomorphic MHC-class I-like molecule, MR1, presents small metabolites to T cells. MR1 is the restriction element for microbe-reactive mucosal-associated invariant T (MAIT) cells. MAIT cells have limited TCR usage, including a semi-invariant TCR alpha chain and express high levels of CD161 and CD26. In addition to microbial lumazine metabolites, recent studies have demonstrated that MR1 is able to capture a variety of diverse chemical entities including folate-derivatives, a number of drug-like and other synthetic small molecules, and as yet undefined compounds of self-origin. This capacity of MR1 to bind distinct ligands likely accounts for the recent identification of additional, non-canonical, subsets of MR1-restricted T (MR1T) cells. These subsets can be defined based on their ability to recognize diverse microbes as well as their reactivity to non-microbial cell-endogenous ligands, including tumor-associated antigens. Herein, we will discuss our current understanding of MR1T cell diversity in terms of TCR usage, ligand recognition and functional attributes.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Heterogeneity; MAIT; MR1; MR1-rescticted T cells; TCR

Mesh:

Substances:

Year:  2020        PMID: 33360378      PMCID: PMC7855563          DOI: 10.1016/j.molimm.2020.12.009

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  39 in total

1.  Diversity of T Cells Restricted by the MHC Class I-Related Molecule MR1 Facilitates Differential Antigen Recognition.

Authors:  Nicholas A Gherardin; Andrew N Keller; Rachel E Woolley; Jérôme Le Nours; David S Ritchie; Paul J Neeson; Richard W Birkinshaw; Sidonia B G Eckle; John N Waddington; Ligong Liu; David P Fairlie; Adam P Uldrich; Daniel G Pellicci; James McCluskey; Dale I Godfrey; Jamie Rossjohn
Journal:  Immunity       Date:  2016-01-12       Impact factor: 31.745

2.  The molecular basis underpinning the potency and specificity of MAIT cell antigens.

Authors:  Wael Awad; Geraldine J M Ler; Weijun Xu; Andrew N Keller; Jeffrey Y W Mak; Xin Yi Lim; Ligong Liu; Sidonia B G Eckle; Jérôme Le Nours; James McCluskey; Alexandra J Corbett; David P Fairlie; Jamie Rossjohn
Journal:  Nat Immunol       Date:  2020-03-02       Impact factor: 25.606

3.  Atypical TRAV1-2- T cell receptor recognition of the antigen-presenting molecule MR1.

Authors:  Wael Awad; Erin W Meermeier; Maria L Sandoval-Romero; Jérôme Le Nours; Aneta H Worley; Megan D Null; Ligong Liu; James McCluskey; David P Fairlie; David M Lewinsohn; Jamie Rossjohn
Journal:  J Biol Chem       Date:  2020-08-14       Impact factor: 5.157

4.  Structural insight into MR1-mediated recognition of the mucosal associated invariant T cell receptor.

Authors:  Rangsima Reantragoon; Lars Kjer-Nielsen; Onisha Patel; Zhenjun Chen; Patricia T Illing; Mugdha Bhati; Lyudmila Kostenko; Mandvi Bharadwaj; Bronwyn Meehan; Ted H Hansen; Dale I Godfrey; Jamie Rossjohn; James McCluskey
Journal:  J Exp Med       Date:  2012-03-12       Impact factor: 14.307

5.  The MAIT TCRβ chain contributes to discrimination of microbial ligand.

Authors:  Gitanjali A Narayanan; James E McLaren; Erin W Meermeier; Kristin Ladell; Gwendolyn M Swarbrick; David A Price; Jessica G Tran; Aneta H Worley; Todd Vogt; Emily B Wong; David M Lewinsohn
Journal:  Immunol Cell Biol       Date:  2020-07-12       Impact factor: 5.853

6.  TCR and Inflammatory Signals Tune Human MAIT Cells to Exert Specific Tissue Repair and Effector Functions.

Authors:  Tianqi Leng; Hossain Delowar Akther; Carl-Philipp Hackstein; Kate Powell; Thomas King; Matthias Friedrich; Zoe Christoforidou; Sarah McCuaig; Mastura Neyazi; Carolina V Arancibia-Cárcamo; Joachim Hagel; Fiona Powrie; Raphael Sanches Peres; Val Millar; Daniel Ebner; Rajesh Lamichhane; James Ussher; Timothy S C Hinks; Emanuele Marchi; Chris Willberg; Paul Klenerman
Journal:  Cell Rep       Date:  2019-09-17       Impact factor: 9.995

7.  Analysis of T cell antigen receptor (TCR) expression by human peripheral blood CD4-8- alpha/beta T cells demonstrates preferential use of several V beta genes and an invariant TCR alpha chain.

Authors:  S Porcelli; C E Yockey; M B Brenner; S P Balk
Journal:  J Exp Med       Date:  1993-07-01       Impact factor: 14.307

8.  Antigen-loaded MR1 tetramers define T cell receptor heterogeneity in mucosal-associated invariant T cells.

Authors:  Rangsima Reantragoon; Alexandra J Corbett; Isaac G Sakala; Nicholas A Gherardin; John B Furness; Zhenjun Chen; Sidonia B G Eckle; Adam P Uldrich; Richard W Birkinshaw; Onisha Patel; Lyudmila Kostenko; Bronwyn Meehan; Katherine Kedzierska; Ligong Liu; David P Fairlie; Ted H Hansen; Dale I Godfrey; Jamie Rossjohn; James McCluskey; Lars Kjer-Nielsen
Journal:  J Exp Med       Date:  2013-10-07       Impact factor: 14.307

9.  MAIT cell clonal expansion and TCR repertoire shaping in human volunteers challenged with Salmonella Paratyphi A.

Authors:  Lauren J Howson; Giorgio Napolitani; Dawn Shepherd; Hemza Ghadbane; Prathiba Kurupati; Lorena Preciado-Llanes; Margarida Rei; Hazel C Dobinson; Malick M Gibani; Karen Wei Weng Teng; Evan W Newell; Natacha Veerapen; Gurdyal S Besra; Andrew J Pollard; Vincenzo Cerundolo
Journal:  Nat Commun       Date:  2018-01-17       Impact factor: 14.919

10.  MR1 displays the microbial metabolome driving selective MR1-restricted T cell receptor usage.

Authors:  Melanie J Harriff; Curtis McMurtrey; Cara A Froyd; Haihong Jin; Meghan Cansler; Megan Null; Aneta Worley; Erin W Meermeier; Gwendolyn Swarbrick; Aaron Nilsen; Deborah A Lewinsohn; William Hildebrand; Erin J Adams; David M Lewinsohn
Journal:  Sci Immunol       Date:  2018-07-13
View more
  3 in total

Review 1.  Unconventional T cells and kidney disease.

Authors:  Hannah Kaminski; Lionel Couzi; Matthias Eberl
Journal:  Nat Rev Nephrol       Date:  2021-08-26       Impact factor: 28.314

Review 2.  Does DPP-IV Inhibition Offer New Avenues for Therapeutic Intervention in Malignant Disease?

Authors:  Petr Busek; Jonathan S Duke-Cohan; Aleksi Sedo
Journal:  Cancers (Basel)       Date:  2022-04-21       Impact factor: 6.575

3.  A novel unconventional T cell population enriched in Crohn's disease.

Authors:  Ilgar Z Mamedov; Petra Bacher; Andre Franke; Elisa Rosati; Gabriela Rios Martini; Mikhail V Pogorelyy; Anastasia A Minervina; Frauke Degenhardt; Mareike Wendorff; Soner Sari; Gabriele Mayr; Antonella Fazio; Christel Marie Dowds; Charlotte Hauser; Florian Tran; Witigo von Schönfels; Julius Pochhammer; Maria A Salnikova; Charlot Jaeckel; Johannes Boy Gigla; Sanaz Sedghpour Sabet; Matthias Hübenthal; Esther Schiminsky; Stefan Schreiber; Philip C Rosenstiel; Alexander Scheffold; Paul G Thomas; Wolfgang Lieb; Bernd Bokemeyer; Maria Witte; Konrad Aden; Alexander Hendricks; Clemens Schafmayer; Jan-Hendrick Egberts
Journal:  Gut       Date:  2022-03-09       Impact factor: 31.793

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.